干细胞类CD4+T细胞调解T细胞状态转换以增强瘤控制和免疫治疗反应
Mamali Das1, Chandramohan Kiruthiga1, Nachammai Kathiresan2
1Department of Biomedical Science, Alagappa University, Karaikudi 630003, Tamil Nadu, India.
International immunopharmacology
|September 1, 2025
概括
类似CD4+T细胞对抗瘤免疫至关重要,驱动长期反应和瘤回归. 了解它们的功能和相互作用是改善癌症免疫治疗和预防复发的关键.
科学领域:
- 免疫学
- 癌症生物学
- 细胞免疫学
背景情况:
- 免疫治疗的突破突显了干细胞CD4+ T细胞在抗瘤免疫中的关键作用.
- 这些自我更新的T细胞分化成效应状态,维持瘤内的免疫反应.
- 独特的表面蛋白和转录特征促进T细胞转换以控制瘤.
研究的目的:
- 审查类似干细胞CD4+T细胞的表型和功能特征.
- 探索状态转换和瘤微环境相互作用的机制.
- 检查这些细胞在瘤回归,免疫治疗和克服耐药性的作用.
主要方法:
- 关于干细胞CD4+T细胞的最新证据的文献综述.
- 分析信号通路和潜在的治疗干预措施.
- 关注检查点抑制剂和CAR-T细胞治疗.
主要成果:
- 类似CD4+T细胞对于启动和维持抗瘤免疫力至关重要.
- 它们的可塑性允许在瘤微环境中适应和持续免疫反应.
- 这些细胞是目前免疫疗法调解的瘤回归的核心.
结论:
- 类似CD4+T细胞对于有效的癌症免疫疗法至关重要.
- 针对这些细胞及其相互作用提供了增强瘤控制和克服抵抗力的潜力.
- 需要进一步的研究和临床转化才能充分利用它们的治疗潜力.
相关概念视频
Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
T Cell Activation and Clonal Selection
4.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
4.5K
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
Cytotoxic T Cells-mediated Immune Response
1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K
Cell-mediated Immune Responses
72.2K
Overview
72.2K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K


